Intellia Therapeutics, Inc. (NTLA) SEC filings
NTLA SEC filings moved a median of -0.47% by the close. NTLA SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the NTLA overview →
73 measured NTLA SEC filing events.
Where these NTLA SEC filings landedvs 73 measured NTLA SEC filing reactions
| Middle 50% of NTLA SEC filing reactions | -2.82% to +2.56% |
|---|---|
| Median reaction (to close) | -0.47% |
| Measured reactions | 73 |
Point-in-time · zero look-ahead
Half of the 73 NTLA SEC filing events with a measured close landed between -2.82% and +2.56%; 41% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 8-K Intellia Therapeutics, For: Sep 08 | SEC filing · Form 8-K | -1.74% | -2.32% | |
| Form 8-K Intellia Therapeutics, For: Sep 04 | SEC filing · Form 8-K | -1.64% | -0.70% | |
| Form 10-Q Intellia Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | -3.63% | -0.33% | |
| Form 8-K Intellia Therapeutics, For: Aug 06 | SEC filing · Form 8-K | +2.63% | +5.64% | |
| Form 8-K Intellia Therapeutics, For: Jun 13 | SEC filing · Form 8-K | +3.16% | +16.75% | |
| Form 8-K Intellia Therapeutics, For: Jun 09 | SEC filing · Form 8-K | -2.30% | +1.40% | |
| Form 10-Q Intellia Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +3.98% | +2.56% | |
| Form 8-K Intellia Therapeutics, For: May 11 | SEC filing · Form 8-K | +3.98% | +2.56% | |
| Form 8-K Intellia Therapeutics, For: Apr 27 | SEC filing · Form 8-K | -1.13% | +0.00% | |
| Form ARS Intellia Therapeutics, For: Dec 31 | SEC filing · Form ARS | -1.13% | +0.00% | |
| Form DEF 14A Intellia Therapeutics, For: Jun 09 | SEC filing · Form DEF | -1.13% | +0.00% | |
| Form DEFA14A Intellia Therapeutics, | SEC filing · Form DEFA14A | -1.13% | +0.00% | |
| Form 8-K Intellia Therapeutics, For: Apr 27 | SEC filing · Form 8-K | -2.39% | -8.36% | |
| Form 8-K Intellia Therapeutics, For: Apr 07 | SEC filing · Form 8-K | +1.35% | +7.22% | |
| Form 8-K Intellia Therapeutics, For: Mar 02 | SEC filing · Form 8-K | -2.28% | +12.05% | |
| Form 10-K Intellia Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +1.00% | -1.36% | |
| Form 8-K Intellia Therapeutics, For: Feb 26 | SEC filing · Form 8-K | -7.85% | +1.49% | |
| Form S-8 Intellia Therapeutics, | SEC filing · Form S-8 | +1.00% | -1.36% | |
| Form 8-K Intellia Therapeutics, For: Jan 27 | SEC filing · Form 8-K | -2.31% | -9.79% | |
| Form 8-K Intellia Therapeutics, For: Jan 09 | SEC filing · Form 8-K | -1.28% | -5.12% | |
| Form 8-K Intellia Therapeutics, For: Nov 08 | SEC filing · Form 8-K | +2.32% | +7.16% | |
| Form 10-Q Intellia Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +4.06% | +4.50% | |
| Form 8-K Intellia Therapeutics, For: Nov 06 | SEC filing · Form 8-K | +4.06% | +4.50% | |
| Form 8-K Intellia Therapeutics, For: Oct 29 | SEC filing · Form 8-K | +3.14% | +4.12% | |
| Form 8-K Intellia Therapeutics, For: Oct 27 | SEC filing · Form 8-K | +10.89% | +7.80% | |
| Form 8-K Intellia Therapeutics, For: Sep 25 | SEC filing · Form 8-K | -1.15% | -1.33% | |
| Form 10-Q Intellia Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | -3.35% | -6.25% | |
| Form 8-K Intellia Therapeutics, For: Aug 07 | SEC filing · Form 8-K | -2.09% | -0.09% | |
| Form 8-K Intellia Therapeutics, For: Jun 15 | SEC filing · Form 8-K | -2.52% | +4.92% | |
| Form 8-K Intellia Therapeutics, For: Jun 11 | SEC filing · Form 8-K | +2.11% | +2.97% | |
| Form S-8 Intellia Therapeutics, | SEC filing · Form S-8 | +0.06% | +1.83% | |
| Form 8-K Intellia Therapeutics, For: May 28 | SEC filing · Form 8-K | -5.28% | +1.22% | |
| Form 8-K Intellia Therapeutics, For: May 18 | SEC filing · Form 8-K | +4.62% | +5.96% | |
| Form 10-Q Intellia Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +2.08% | -3.56% | |
| Form 8-K Intellia Therapeutics, For: May 08 | SEC filing · Form 8-K | -5.48% | +5.34% | |
| Form ARS Intellia Therapeutics, For: Dec 31 | SEC filing · Form ARS | -4.38% | -2.92% | |
| Form DEF 14A Intellia Therapeutics, For: Jun 11 | SEC filing · Form DEF | -4.38% | -2.92% | |
| Form DEFA14A Intellia Therapeutics, | SEC filing · Form DEFA14A | -4.38% | -2.92% | |
| Form 8-K Intellia Therapeutics, For: Apr 03 | SEC filing · Form 8-K | -3.07% | +5.65% | |
| Form S-8 Intellia Therapeutics, | SEC filing · Form S-8 | +1.72% | -7.17% | |
| Form 10-K Intellia Therapeutics, For: Dec 31 | SEC filing · Form 10-K | -6.72% | -1.75% | |
| Form 8-K Intellia Therapeutics, For: Feb 27 | SEC filing · Form 8-K | +1.02% | -3.89% | |
| Form 8-K Intellia Therapeutics, For: Feb 18 | SEC filing · Form 8-K | +0.00% | -4.24% | |
| Form 8-K Intellia Therapeutics, For: Jan 09 | SEC filing · Form 8-K | -3.74% | -9.25% | |
| Form 8-K Intellia Therapeutics, For: Nov 16 | SEC filing · Form 8-K | +2.86% | -2.48% | |
| Form 10-Q Intellia Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | -1.56% | +4.24% | |
| Form 8-K Intellia Therapeutics, For: Nov 07 | SEC filing · Form 8-K | +1.17% | -1.24% | |
| Form 8-K Intellia Therapeutics, For: Oct 24 | SEC filing · Form 8-K | +1.12% | +1.87% | |
| Form 10-Q Intellia Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | -0.36% | -4.20% | |
| Form 8-K Intellia Therapeutics, For: Aug 08 | SEC filing · Form 8-K | -1.13% | +1.36% | |
| Form S-8 Intellia Therapeutics, | SEC filing · Form S-8 | -1.49% | -4.02% | |
| Form 8-K Intellia Therapeutics, For: Jun 21 | SEC filing · Form 8-K | -1.59% | -3.98% | |
| Form 8-K Intellia Therapeutics, For: Jun 12 | SEC filing · Form 8-K | -0.50% | +0.68% | |
| Form 8-K Intellia Therapeutics, For: Jun 12 | SEC filing · Form 8-K | +0.46% | -2.82% | |
| Form 10-Q Intellia Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +0.20% | -2.16% | |
| Form 8-K Intellia Therapeutics, For: May 09 | SEC filing · Form 8-K | -3.71% | +0.93% | |
| Form ARS Intellia Therapeutics, For: Dec 31 | SEC filing · Form ARS | -0.28% | -0.47% | |
| Form DEF 14A Intellia Therapeutics, For: Jun 12 | SEC filing · Form DEF | -0.28% | -0.47% | |
| Form DEFA14A Intellia Therapeutics, | SEC filing · Form DEFA14A | -0.28% | -0.47% | |
| Form PRE 14A Intellia Therapeutics, For: Jun 12 | SEC filing · Form PRE | +0.16% | -2.00% | |
| Form 8-K Intellia Therapeutics, For: Apr 10 | SEC filing · Form 8-K | -0.91% | -3.58% | |
| Form 8-K Intellia Therapeutics, For: Mar 19 | SEC filing · Form 8-K | -0.94% | -2.57% | |
| Form 8-K Intellia Therapeutics, For: Feb 23 | SEC filing · Form 8-K | +2.80% | +7.42% | |
| Form 10-K Intellia Therapeutics, For: Dec 31 | SEC filing · Form 10-K | -0.30% | -2.32% | |
| Form 8-K Intellia Therapeutics, For: Feb 22 | SEC filing · Form 8-K | -0.98% | +2.57% | |
| Form S-8 Intellia Therapeutics, | SEC filing · Form S-8 | -0.30% | -2.32% | |
| Form 8-K Intellia Therapeutics, For: Jan 31 | SEC filing · Form 8-K | -0.29% | +3.48% | |
| Form 8-K Intellia Therapeutics, For: Jan 04 | SEC filing · Form 8-K | -3.02% | -0.69% | |
| Form 8-K Intellia Therapeutics, For: Dec 05 | SEC filing · Form 8-K | -1.48% | -1.68% | |
| Form S-3ASR Intellia Therapeutics, | SEC filing · Form S-3ASR | -1.25% | +0.37% | |
| Form 10-Q Intellia Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | -0.88% | -3.71% | |
| Form 8-K Intellia Therapeutics, For: Nov 09 | SEC filing · Form 8-K | -5.39% | -12.42% | |
| Form 8-K Intellia Therapeutics, For: Nov 02 | SEC filing · Form 8-K | +0.42% | +1.46% |
Keep exploring
More NTLA: earnings → · analyst actions → · NTLA overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Sage Therapeutics, Inc. (SAGE) | 951 | -0.14% | 41% |
| Geron Corporation (GERN) | 949 | -0.28% | 41% |
| Biohaven Ltd. Common Shares (BHVN) | 944 | -0.27% | 45% |
| GW PHARMACEUTICALS PLC AMERICA (GWPH) | 942 | -0.06% | 47% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.